April 29, 2014

 “Large and In Charge vs. Small, but Mighty” – Who Makes a Better Licensing Partner: Established Global Pharmaceuticals Companies or Emerging Specialty Pharma and Biotech Players? Panelists: George Golumbeski, Sr. Vice President, BD,  Celgene; Jeff Jonker, SVP, BD, Theravance; Gary Phillips, Managing Director, Chief Strategy Officer, Mallinckrodt Pharma; James Mackay, President and Chief Operating Officer, Ardea Biosciences and AstraZeneca Global Product VP; Lesinurad Fran Heller, SVP, Business Development, BMS.